Trinity Biotech Plc (TRIB)
1.21
+0.11
(+10.00%)
USD |
NASDAQ |
Dec 09, 13:11
Trinity Biotech EPS Diluted (Quarterly): -0.4812 for March 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DBV Technologies SA | -1.207 |
| Cellectis SA | 0.0058 |
| Akari Therapeutics Plc | -0.1948 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.804M |
| Revenue (Quarterly) | 7.576M |
| Total Expenses (Quarterly) | 16.38M |
| Enterprise Value | 124.40M |
| Gross Profit Margin (Quarterly) | 20.67% |
| Profit Margin (Quarterly) | -116.2% |
| Earnings Yield | -241.6% |
| Normalized Earnings Yield | -207.12 |